Neuropsychology and Psychopharmacology (NP&PP) is one of the research departments of the Faculty of Psychology and Neuroscience. We perform fundamental and applied behavioural and cognitive neuroscience research on the brain-cognition relationship adopting a lifespan perspective, and assess biological mechanisms that underlie cognitive, affective, and behavioural functions by means of controlled pharmacological interventions.
Neuropsychology investigates the influence of biological, physiological, cognitive, affective, and psychosocial parameters on healthy development and aging as well as on congenital and acquired brain damage. We focus on cognitive functions and dysfunctions and their behavioural and emotional consequences, emphasising neuropsychological conditions relevant in healthy and pathological development across the lifespan. NP is headed by Sonja Kotz.
The Psychopharmacology unit is mainly focused on the neurochemical basis of various behavioural functions such as memory, attention, psychomotor performance, mood, and addiction. The unit is world leader in on the road testing of medicinal and illicit drugs. PP is headed by Wim Riedel.
NP&PP runs three master's programmes to which members of both sections equally contribute.
“Our standardised psychomotor and on-the-road driving tests and analyses for measuring (medicinal) drug influences on behaviour have strongly contributed to current guidelines on evaluating drug induced impaired driving as recommended by regulatory authorities such as the Food and Drug Administration (FDA).”
“The research in the field of clinical neuropsychology has both scientific as well as societal impact as many research products, such as diagnostic tools and treatment protocols which can be directly implemented in daily clinical practice .”
“Although some nutrients may moderately influence emotional-cognitive performance in certain vulnerable subjects; most claims about food, the brain and behaviour are overstated and could not be scientifically supported.”